Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 5, 1996, Pages 408-415

  Cohn, Susan E ^a   Klein, Jonathan D ^b   Weinstein, Robert A ^c   Shapiro, Martin F ^d   DeHovitz, Jack A ^e   Kessler, Harold A ^f   Dickinson, Gordon M ^g   Rodrigue, Daniel C ^h   Bennett, Charles L ⁱ  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c Jr Hospital of Cook County   (United States)

^d RAND CORPORATION   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f RUSH MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AIDS; Mortality; Physician practice patterns; Pneumocystis carinii pneumonia; Regional variation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE CONTROL; DISEASE SEVERITY; DISEASE TRANSMISSION; GEOGRAPHY; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PNEUMOCYSTIS CARINII;

EID: 0030468033     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199612150-00002     Document Type: Article

References (33)

1. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992:326: 1097-101.
2. Detsky AS. Regional variation in medical care. N Engl J Med 1995;333:589-90.
3. Chassin MR, Kosecoff J, Park RE, et al. Does inappropriate use explain geographic variations in the use of health care services? JAMA 1987:258:2533-7.
4. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-90.
5. Wachter RM, Luce JM, Safrin S, Berriois DC, Charlebois E, Scitovsky AA. Cost and outcome of intensive care for patients for AIDS. Pneumocystis carinii pneumonia, and severe respiratory failure. JAMA 1994;273:230-5.
6. Bozzette SA, Finkelstein DM, Spector SA, et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med 1995;332:693-9.
7. Masur H. Prevention and treatment of pneumocystis pneumonia. N Engl J Med 1992;327:1853-60.
8. Kaplowitz LG, Turshen IJ, Myers PS, et al. Medical care costs of patients with acquired immunodeficiency syndrome in Richmond, VA. Arch Intern Med 1988;148:1793-7.
9. Kelly JV, Ball JK, Turner BJ. Duration and costs of AIDS hospitalizations in New York: variations by patient severity of illness and hospital type. Med Care 1989;27:1085-98.
10. Turner BJ, Ball JK. Variations in inpatient mortality for AIDS in a national sample of hospitals. J Acquir Immune Defic Syndr 1992;5:978-87.
11. Ball JK, Turner BJ. AIDS in U.S. hospitals, 1986-1987: a national perspective. Rockville, MD: Public Health Service, 1991; AHCPR publication no. (AHCPR) 91-0015. (Hospital Studies Program Research note 15, Agency for Health Care Policy and Research.)
12. Bennett CL, Adams J, Bennett RL, et al. The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs hospitals 1987-1991. J Acquir Immune Defic Syndr 1995;8:373-8.
13. Andrulis DP, McGregor CM, Weiss KB, Ramirez KL, Ginsberg CA, Shaw-Taylor Y. U.S. hospital care for HIV-infected persons are the role of public and private hospitals 1988-1991. J Acquir Immune Defic Syndr 1995;9:193-203.
14. Markson LE, McKee L, Mauskopf J. Patterns of Medicaid expenditures after AIDS diagnosis. Health Care Finan Rev 1994;15:43-59.
15. Cleary PD, Greenfield S, Mulley AG, et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA 1991;266:73-9.
16. Oken C, Archibald N, Cvitanic M, Biddle A, Shapiro MF, Bennett CL. Multicity study of quality of care for HIV-related Pneumocystis carinii pneumonia: successfully collecting highly sensitive information. Clin Perf Qual Health Care 1995;3:140-6.
17. Bennett CL, Weinstein RA, Shapiro MF, et al. A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1994;150:1503-7.
18. Bennett CL, Horner RD, Weinstein RA, et al. Racial differences in care hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami and Raleigh Durham. Arch Intern Med 1995;155:1586-92.
19. CDC. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:1-15S.
20. American Hospital Association. 1988 AHA survey of hospitals. Chicago, IL: Hospital Information Services, 1988.
21. Fine MJ, Singer DE, Phelps AL, et al. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care 1993;31:371-80.
22. The National Institutes of Health-University of California Expert panel for corticosteroids as adjunctive therapy for Pneumocystis pneumonia. Consensus statement on the use of corticosteroids as adjunct therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1500-4.
23. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med 1989;320:1388-93.
24. Knaus WA, Wagner DP, Zimmerman JE, et al. Variations in mortality and length of stay in intensive care units. Ann Intern Med 1993;118:753-61.
25. Burns LR, Wholey DR. The effects of patient, hospital, and physician characteristics on length of stay and mortality. Med Care 1991;29:251-71.
26. Epstein AM, Stern RS, Tognetti J, et al. The association of patients' socioeconomic characteristics with the length of hospital stay and hospital charges within diagnosis-related groups. N Engl J Med 1988;318:1579-85.
27. Bennett CL, Graf L, Young N, Daley J, Makadon H. Intensity of in-hospital care for persons with AIDS. J Acquir Immune Defic Syndr 1991;4:856-60.
28. Dohn MN, Baughman RP, Vigdorth EM, Frame I. Survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia on patients with acquired immunodeficiency syndrome. Arch Intern Med 1992;152:2465-70.
29. Harris JE. Improved short term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA 1990;263:397-401.
30. Lemp GF, Payne SF, Neal D, Temelso R, Rutherford GW. Survival trends for patients with AIDS. JAMA 1990;263:402-6.
31. O'Brien RF, Quinn JL, Miyahara BT, Lepoff RB, Cohn DL. Diagnosis of Pneumocystis carinii pneumonia by induced sputum in a city with moderate incidence of AIDS. Chest 1989;95:136-8.
32. Kovacs JA, Ng VL, Masur H, et al. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med 1988;318:589-93.
33. Huang L, Hecht FM, Stansell JD, Montanti R, Hadley WK, Hopewell PC. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful? Am J Resp Crit Care Med 1995;151:1866-71.